|
ASAP2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.638900E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.017700E-03 |
| Normal-vs-Stage2 |
4.868200E-01 |
| Normal-vs-Stage3 |
2.099900E-02 |
| Normal-vs-Stage4 |
1.276320E-02 |
| Stage1-vs-Stage2 |
1.390270E-02 |
| Stage1-vs-Stage3 |
7.884200E-01 |
| Stage1-vs-Stage4 |
9.958800E-01 |
| Stage2-vs-Stage3 |
2.524100E-02 |
| Stage2-vs-Stage4 |
2.328500E-02 |
| Stage3-vs-Stage4 |
8.111400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.396000E-04 |
| Normal-vs-AfricanAmerican |
1.062760E-01 |
| Normal-vs-Asian |
7.801600E-02 |
| Caucasian-vs-AfricanAmerican |
8.980600E-01 |
| Caucasian-vs-Asian |
6.292800E-01 |
| AfricanAmerican-vs-Asian |
6.617400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.097800E-02 |
| Normal-vs-Female |
2.422800E-03 |
| Male-vs-Female |
5.288200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.561400E-04 |
| Normal-vs-Age(41-60Yrs) |
7.664200E-03 |
| Normal-vs-Age(61-80Yrs) |
7.900800E-01 |
| Normal-vs-Age(81-100Yrs) |
6.152400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.386400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.395500E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.928250E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.409700E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.488200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.941200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.563800E-01 |
| Classical-VS-Follicular |
1.62436730732907E-12 |
| Classical-VS-Other |
3.563000E-01 |
| Classical-VS-Normal |
3.52449999962978E-07 |
| Tall-VS-Follicular |
4.53439508163456E-11 |
| Tall-VS-Other |
2.878200E-01 |
| Tall-VS-Normal |
1.67318999999555E-05 |
| Follicular-VS-Other |
3.400200E-02 |
| Follicular-VS-Normal |
1.7470399999997E-05 |
| Other-VS-Normal |
7.101200E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.804000E-01 |
| Normal-vs-N1 |
3.014100E-02 |
| N0-vs-N1 |
4.193800E-02 |
|
|
